Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
about
Management of Type 1 Diabetes in PregnancyPrimary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectivesHydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysisMaternal microchimerism: friend or foe in type 1 diabetes?Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportDisease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Environmental risk factors for type 1 diabetesType 1 diabetes mellitus.Type 1 diabetes in Sardinia: facts and hypotheses in the context of worldwide epidemiological data.Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults.Early prediction of autoimmune (type 1) diabetes.Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Immune therapy for treating type 1 diabetes: challenging existing paradigms.Role of the gastrointestinal ecosystem in the development of type 1 diabetes.Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Microbiota and autoimmunity: exploring new avenues.Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at preventionAssociation of environmental markers with childhood type 1 diabetes mellitus revealed by a long questionnaire on early life exposures and lifestyle in a case-control study.The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?Blood-based signatures in type 1 diabetes.Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin.Infant Feeding and Timing of Complementary Foods in the Development of Type 1 Diabetes.New Insights and Biomarkers for Type 1 Diabetes: Review for Scandinavian Journal of Immunology.Can we prevent type 1 diabetes?Autoimmune diseases and celiac disease which came first: genotype or gluten?Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes.WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts.Islet Autoantibodies.Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.Current and future efforts toward the prevention of type 1 diabetes.Role of humoral beta-cell autoimmunity in type 1 diabetes.Dietary factors in the development of type 1 diabetes.Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetesFirst Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study.Genetic and environmental factors affect the onset of type 1 diabetes mellitus.Is there a role for gut microbiota in type 1 diabetes pathogenesis?Recognition of ZnT8, Proinsulin, and Homologous MAP Peptides in Sardinian Children at Risk of T1D Precedes Detection of Classical Islet Antibodies.8th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG): April 16-18, 2015, Republic of Malta.
P2860
Q26747535-5745FC23-80F8-4E5E-8455-B1B5443B71D6Q26748984-040156FC-F0D2-45E3-BAA0-FA7A2B96E2E7Q26767145-3E3C21BD-F875-47E8-A3DC-2002E152E559Q26851151-1BDB9E7C-6123-495C-8D1A-8766FA5579EEQ27687598-8194939E-A3B4-4992-A3E7-579342BE36D1Q28081034-FB4664AD-D340-4751-A5F9-AF9C26554306Q28276366-E2C97C1A-B954-4435-9BFE-BA1426746478Q30235021-64B09D83-7366-46C0-B23D-0C72A8F07F0CQ30245271-D8C8B140-CE46-43BD-AD04-BCE81D846A1BQ33785703-6DF95657-788A-4899-9E94-1CBFE16C8097Q33854613-AF1CB5C3-844B-4257-AB17-98189B221E4AQ34553284-556DB1D2-582D-439B-8CC9-F6BC70EFE3AEQ35242386-F7916894-1ECE-47D1-AD0C-AC5507CBF097Q35624584-889695DE-0E7D-4648-9E37-38AF93B81061Q35630698-1C44ADC2-94B6-468B-A715-8DB856C92693Q35631728-D008F47D-2ADA-46A7-90D0-D38228C71082Q36117948-D3DC23A9-9AD7-4A8F-8B98-5E79BBC2FF21Q36147370-F5DD85AA-58EF-465C-99B9-D12409588F12Q36263439-671E4E99-49F5-4A84-BD47-6AF7CA076AF0Q36552481-CBD81FD5-D5F1-4078-8C31-5DA862594CD9Q36628149-8306BBF5-934A-4E04-9017-0ACF7A200084Q37621822-1D4C81B6-F386-4916-8FB4-25762B9F4CE6Q38539481-21A18927-2A09-4AE6-BEF2-CA2635B12D0BQ38586895-0FC5924A-5B83-4EF5-A6BA-E9D3425E5EE1Q38608380-E3426838-3F8C-4BE5-9918-5AE149C5D112Q38650009-12A14863-E86D-4CE3-B97C-075112826422Q38764804-9B3220CE-42CE-4B2C-9D2E-FBEC60743859Q38795235-F57EA170-41B9-4E76-8888-A3D8F134D0B4Q38817211-42865522-F960-40FA-9086-8EADB8623A0AQ38828063-0670776A-CC65-49E3-9C1A-0B166D0C76C4Q38842306-76095CED-F17E-4EA8-869E-458FB38775E2Q38842309-E6104504-BE49-41C1-B587-338A25C594B5Q38895419-89553BB4-D6CB-495E-A862-946FC29AF68AQ38950436-2F119429-3F6B-40C9-83B8-34E7F82A38BFQ39306726-2A52A95A-A831-42E2-A28C-9FC6BC6706A2Q40376839-62245F2F-12A1-4695-B8F7-ECD8921FB636Q40469552-9F080AD1-6156-43A5-88CA-1E8B397C8AF0Q40631825-6392C82B-41C7-4881-9C3F-EBAFACBAECB0Q40813098-10CA461E-3556-40FC-8682-EF48EC36A613Q42625616-67EF9062-2B21-47B3-8588-ED0006BB4FDE
P2860
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@ast
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@en
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@nl
type
label
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@ast
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@en
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@nl
prefLabel
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@ast
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@en
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@nl
P2093
P2860
P50
P356
P1476
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
@en
P2093
Dorothy Becker
Erkki Savilahti
Hans K Åkerblom
Hans-Michael Dosch
Jeffrey P Krischer
Jerry P Palmer
John Dupre
Neville Howard
Olga Kordonouri
Outi Vaarala
P2860
P304
P356
10.1001/JAMA.2014.5610
P407
P577
2014-06-01T00:00:00Z